Twenty-four Year Single-Center Experience of Hepatitis B Virus Infection in Heart Transplantation

Transplantation Proceedings, 05/11/2012

Hepatitis B virus (HBV) reactivation after the heart transplantation was common but usually well controlled with lamivudine treatment. Although posttransplantation liver function deteriorated for a period, there was no HBV infection–related morbidity or mortality. Perioperative hepatitis B immunoglobulin prophylaxis can successfully prevent HBV na├»ve recipients from infection in some cases, but hepatitis B surface antigen–positive donors should only be considered in high risk situations.

Print Article Summary